Persones / Equip Humà

Francesc Villarroya Gombau

Buscador de publicacions

Publicacions

  • Gavaldà-Navarro A, Moreno-Navarrete JM, Quesada T, Cairo M, Giralt M, Fernández-Real JM and Villarroya-Gombau F.

    Lipopolysaccharide-binding protein is a negative regulator of adipose tissue browning in mice and humans

    Diabetologia . 59(10): 2208-2218. Nº de cites: 32

    [doi:10.1007/s00125-016-4028-y]

  • Zarei M, Barroso E, Leiva R, Barniol-Xicota M, Pujol E, Escolano C, Vázquez S, Palomer X, Pardo V, González-Rodríguez Á, Valverde ÁM, Quesada-López T, Villarroya-Gombau F, Wahli W and Vázquez-Carrera M.

    Heme-regulated eIF2a kinase modulates hepatic FGF21 and is activated by PPARß/d deficiency

    Diabetes . 65(10): 3185-3199. Nº de cites: 30

    [doi:10.2337/db16-0155]

  • Moure R, Domingo P, Gallego-Escuredo JM, Villarroya-Terrade J, Gutierrez Mdel M, Mateo MG, Domingo JC, Giralt M and Villarroya-Gombau F.

    Impact of elvitegravir on human adipocytes: Alterations in differentiation, gene expression and release of adipokines and cytokines.

    ANTIVIR RES . 132: 59-65. Nº de cites: 44

    [doi:10.1016/j.antiviral.2016.05.013]

  • Giralt M, Cairo M and Villarroya-Gombau F.

    Hormonal and nutritional signalling in the control of brown and beige adipose tissue activation and recruitment.

    BEST PRACT RES CL EN . 30(4): 515-525. Nº de cites: 12

    [doi:10.1016/j.beem.2016.08.005]

  • Ejaz A, Martínez-Guino L, Goldfine AB, Ribas-Aulinas F, De Nigris V, Ribó-Gené S, Gonzalez-Franquesa A, Garcia-Roves PM, Li E, Dreyfuss JM, Gall W, Kim JK, Bottiglieri T, Villarroya-Gombau F, Gerszten RE, Patti ME and Lerin C.

    Dietary Betaine Supplementation Increases Fgf21 Levels to Improve Glucose Homeostasis and Reduce Hepatic Lipid Accumulation in Mice

    Diabetes . 65(4): 902-912. Nº de cites: 73

    [doi:10.2337/db15-1094]

  • Jeanson Y, Ribas F, Galinier A, Arnaud E, Ducos M, André M, Chenouard V, Villarroya-Gombau F, Casteilla L and Carrière A.

    Lactate induces FGF21 expression in adipocytes through a p38-MAPK pathway.

    BIOCHEMICAL JOURNAL . 473(6): 685-692. Nº de cites: 40

    [doi:10.1042/BJ20150808]

  • Montero-Sanchez R, Yubero-Siles D, Villarroya-Terrade J, Henares-Bonilla D, Jou-Munoz C, Rodríguez-García MA, Ramos F, Nascimento-Osorio A, Ortez-Gonzalez CI, Campistol-Plana J, Pérez-Dueñas B, O'Callaghan-Gordo M, Pineda M, Garcia-Cazorla A, Colomer J, Montoya J, Ruiz-Pesini E, Emperador S, Meznaric M, Campderros L, Kalko SG, Villarroya-Gombau F, Artuch-Iriberri R and Jimenez-Mallebrera C.

    GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction

    PLoS One . 11(2): . Nº de cites: 119

    [doi:10.1371/journal.pone.0148709]

  • Redondo-Angulo I, Mas-Stachurska A, Sitges M, Giralt M, Villarroya-Gombau F and Planavila A.

    C/EBPß is required in pregnancy-induced cardiac hypertrophy.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 202: 819-828. Nº de cites: 11

    [doi:10.1016/j.ijcard.2015.10.005]

  • Giralt M, Cereijo R and Villarroya-Gombau F.

    Adipokines and the Endocrine Role of Adipose Tissues.

    Handbook of Experimental Pharmacology . 233: 265-282. Nº de cites: 53

    [doi:10.1007/164_2015_6]

  • Giralt M, Gavaldà-Navarro A and Villarroya-Gombau F.

    Fibroblast growth factor-21, energy balance and obesity.

    MOLECULAR AND CELLULAR ENDOCRINOLOGY . 418 Pt 1: 66-73. Nº de cites: 103

    [doi:10.1016/j.mce.2015.09.018]